Novocure Announces Presence at American Society for Radiatio

ROOT, Switzerland, September 29, 2023--Novocure (NASDAQ: NVCR) today announced its participation in the upcoming American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting from October 1 – 4 in San Diego. Presentations will describe preclinical, clinical and simulation modeling studies on Tumor Treating Fields (TTFields) therapy, including new insights about methods to optimize TTFields intensities delivered at the target tumor during treatment.

Related Keywords

New Hampshire , United States , San Diego , California , Switzerland , Israel , Tokyo , Japan , Pritesh Shah , Nadav Shapira , Brian Berger , Matthew Ballo , Luis Carranza Pena , Narasimha Kumar Karanam , Ingrid Goldberg , Twitter , Exchange Commission , American Society For Radiation Oncology , American Society , Radiation Oncology , Tumor Treating Fields , Chief Growth , Body Mass Index , Intensity Distribution , Specific Segmentation Based Treatment Planning , Factors Limiting Optune Initiation , Luis Carranza , Treating Fields , Real World , Newly Diagnosed Glioblastoma , Survival Meta Analysis With Systematic , Topical Products , Manage Skin Irritation Associated With , Narasimha Kumar , Therapy Framework , Tumor Treating Fields Layouts , Effective Treatment , Tumor Treating , Annual Report , Private Securities Litigation Reform Act ,